GTS Securities’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,100
Closed -$249K 4015
2024
Q1
$249K Buy
+20,100
New +$262K ﹤0.01% 3152
2023
Q4
Sell
-13,900
Closed -$205K 4114
2023
Q3
$205K Buy
+13,900
New +$195K ﹤0.01% 3390

Other funds holding DVAX

GTS Securities's DVAX Position: Q2 2024 in Review

GTS Securities sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 40,029 shares — an estimated $497K sold.

GTS Securities first reported a position in DVAX in Q2 2023 and held it in 4 quarters. The position peaked at $497K in Q1 2024. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • GTS Securities reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • GTS Securities sold 40,029 Dynavax Technologies shares in Q2 2024, an estimated $497K.
  • GTS Securities first reported a position in Dynavax Technologies in Q2 2023 and held it in 4 quarters.
  • GTS Securities's Dynavax Technologies position peaked at $497K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.